AMWatch

Ambitiøs biotekfond lukker ned før første investering

Ambitionerne var store, da Sund Capital med tidligere Zealand Pharma-direktør David Solomon i spidsen, annoncerede, at man ville rejse op mod to mia. kr. til investeringer i lovende biotekselskaber. Nu lukker fonden ned.

Photo: /ritzau scanpix/Søren Bidstrup

Med et tab på samlet 2,9 mio. kr. efter halvandets års drift bliver der nu sat punktum for investeringsfonden Sund Capital, der i sommeren 2016 blev sat i verden med ambition om at investere op mod 2,2 mia. kr. i nordiske biotekselskaber.

Det fremgår af fondens første regnskab, der dækker perioden fra 5. august 2016 til 31. december 2017.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Evli's new fund aims for EUR 300m portfolio

Finland's net rental yield is at an attractive level even by international standards, and international investors have noticed this over the past five years, says Tero Tuominen, who heads the Evli Residential II fund.

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch